Answers are grounded in this paper and cite their sources.
Cross-sectional study shows dietary patterns impact IL-6 levels in platelet-rich plasma, indicating potential clinical relevance.
Background/Objectives: Platelet-rich plasma (PRP) is increasingly used in musculoskeletal medicine. Variability in PRP composition, driven by preparation- and donor-related factors, is considered a major contributor to inconsistent clinical outcomes. This study investigated whether habitual dietary patterns are associated with the cellular and molecular composition of leukocyte-poor PRP (LP-PRP). Methods: In this cross-sectional study, 75 healthy adults (25 vegans, 25 vegetarians, and 25 omnivores) who adhered to their dietary patterns for ≥6 months were enrolled. LP-PRP was prepared by a standardized protocol. Cell profiles were quantified in whole blood and LP-PRP; LP-PRP proteins (IL-6, IGF-1, HGF, and PDGF-BB) were measured by ELISA. Group differences, correlations, and multivariable regressions were performed. Results: Whole blood differed by diet with respect to total leukocytes, lymphocytes, and basophils, while platelet and erythrocyte counts did not. In LP-PRP, platelet enrichment ratios and leukocyte counts were comparable across diets. IL-6 in LP-PRP was lower in vegans vs. omnivores (p = 0.017); the Animal-Based Diet Score correlated positively with LP-PRP IL-6 and remained independently associated in regression (β = 0.35, p = 0.004). While IGF-1, HGF, and PDGF-BB did not differ between dietary groups, intake-based analyses revealed associations between specific dietary components and LP-PRP proteins; notably, the fruit and vegetable intake correlated inversely with PDGF-BB, and platelet–growth factor coupling was most pronounced among omnivores. Conclusions: Dietary patterns were associated with selected molecular components of LP-PRP—most consistently IL-6—while cell counts remain largely unchanged. However, interventional studies are needed to establish causality and determine whether dietary modification can influence clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Platzer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: